Results 81 to 90 of about 1,553,093 (290)
Molecular Oncology, EarlyView.This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima +6 more
wiley +1 more source
The Truth about the Trusts. A Description and Analysis of the American Trust Movement
, 1904 John H. Moody
openalex +2 more sources
Monopolies and Trusts. Richard T. ElyThe Trust Problem. Jeremiah Whipple Jenks [PDF]
, 1900 A. C. M.
openalex +1 more source
Molecular Oncology, EarlyView.Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source
An Integrative Model Of Organizational Trust
, 1995 R. Mayer, J. H. Davis, F. Schoorman
semanticscholar +1 more source
Molecular Oncology, EarlyView.Single‐cell transcriptomics of prostate cancer patient‐derived xenografts reveals distinct features of neuroendocrine (NE) subtypes. Tumours with focal NE differentiation (NED) share transcriptional programmes with adenocarcinoma, differing from large and small cell neuroendocrine prostate cancer (NEPC). Our work defines the molecular landscape of NEPC,
Rosalia Quezada Urban +12 more
wiley +1 more source
The Trust Problem in the United States.
, 1924 Henry W. Macrosty, Eliot Jones
openalex +2 more sources
Developing and Validating Trust Measures for e-Commerce: An Integrative Typology
Information systems research, 2002 D. Harrison +3 more
semanticscholar +1 more source